Menu
Recruiting NCT07743892

Obstructive Sleep Apnea and Body Awareness

Observational Obstructive Sleep Apnea (OSAS)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Obstructive Sleep Apnea (OSAS). Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Relationship Between Body Awareness and Clinical Parameters in Patients With Obstructive Sleep Apnea

Overview

Obstructive Sleep Apnea Syndrome (OSAS) is a chronic disease characterized by intermittent hypoxia and sleep fragmentation resulting from recurrent upper airway obstructions. The physiological and neurocognitive changes caused by the disease can affect how individuals perceive and interpret bodily sensations. Although body awareness plays a significant role in the perception and management of symptoms, its relationship with clinical parameters in individuals with OSAS has not been sufficiently investigated. Therefore, the aim of our study is to examine the relationship between body awareness and respiratory function, disease severity, fatigue, shortness of breath, and sleep quality in OSAS patients.

Primary outcome measures

  • Body awareness [Time frame: Baseline]
  • Dyspnea [Time frame: Baseline]
  • Disease severity [Time frame: Baseline]
  • Fatigue severity [Time frame: Baseline]
  • Sleep quality [Time frame: Baseline]
  • Pulmonary function (Forced vital capacity (FVC) [Time frame: Baseline]
  • Pulmonary function (Forced expiratory volume in the first second (FEV1) [Time frame: Baseline]
  • Pulmonary function (FEV1 / FVC) [Time frame: Baseline]
  • Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%)) [Time frame: Baseline]
  • Pulmonary function (Peak flow rate (PEF)) [Time frame: Baseline]

Eligibility criteria

Inclusion criteria

  • Receiving a diagnosis of OSA after polysomnography,
  • Having an Apnea-Hypopnea Index ≥5 for OSA,
  • Volunteering to participate in the study.

Exclusion criteria

  • Having severe orthopedic, neurological, or cardiac diseases,
  • Having a diagnosed lung disease,
  • Having a previous or current history of psychiatric or neurological disorders,
  • Not voluntarily participating in the study.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-only

Study locations

Turkey (Türkiye) · 1 center
  • Karabük Training and Research Hospital — Karabük

Identifiers

NCT: NCT07743892 · Karabuk_005

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗